Ipilimumab administered to metastatic melanoma patients who progressed after dendritic cell vaccination

Background: Ipilimumab has proven to be effective in metastatic melanoma patients. The purpose of this study was to determine the efficacy of ipilimumab in advanced melanoma patients who showed progressive disease upon experimental dendritic cell (DC) vaccination. Methods: Retrospective analysis of...

Descripción completa

Detalles Bibliográficos
Autores principales: Boudewijns, Steve, Koornstra, Rutger H. T., Westdorp, Harm, Schreibelt, Gerty, van den Eertwegh, Alfons J. M., Geukes Foppen, Marnix H., Haanen, John B., de Vries, I. Jolanda M., Figdor, Carl G., Bol, Kalijn F., Gerritsen, Winald R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007966/
https://www.ncbi.nlm.nih.gov/pubmed/27622070
http://dx.doi.org/10.1080/2162402X.2016.1201625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007966/
https://www.ncbi.nlm.nih.gov/pubmed/27622070
http://dx.doi.org/10.1080/2162402X.2016.1201625

Ejemplares similares